Juan-Carlos García-Pagán, Jorge Gracia-Sancho, Jaume Bosch 

Slides:



Advertisements
Similar presentations
03/06/021 K June /06/ Vascular Smooth Muscle Cells Endothelium Neural Other Tissues Intrinsic Factors Regulation of Flow (Q)
Advertisements

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Cirrhotic Cardiomyopathy J Am Coll Cardiol. 2010;56(7):
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Polymorphisms in endothelial nitric oxide synthase and atherogenesis
Volume 46, Issue 3, Pages (March 2007)
From: Nitric Oxide: A Physiologic Messenger
Endothelium-derived mediators: the vasodilators prostacyclin (PGI2) and nitric oxide (NO) and the vasoconstrictor endothelin (ET-1). Endothelium-derived.
Volume 53, Issue 3, Pages (September 2010)
Carmen Peralta, Mónica B. Jiménez-Castro, Jordi Gracia-Sancho 
Manuel Mas  European Urology Supplements 
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Prevention of ischemia-reperfusion injury in cardiac surgery: Therapeutic strategies targeting signaling pathways  Kay Maeda, MD, PhD, Marc Ruel, MD,
Recent insights on the mechanisms of liver preconditioning
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
HFpEF, a Disease of the Vasculature: A Closer Look at the Other Half
Long-acting oral phosphodiesterase inhibition preconditions against reperfusion injury in an experimental lung transplantation model  Eric S. Weiss, MD,
Volume 47, Issue 1, Pages (July 2007)
The key pathways and classes of drugs that have been approved for the treatment of pulmonary arterial hypertension. The key pathways and classes of drugs.
Immigration and viral hepatitis
Gene Therapy for Erectile Dysfunction: Fact or Fiction?
Vascular endothelial dysfunction in cirrhosis
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Human serum albumin, systemic inflammation, and cirrhosis
Figure 3 The mechanism of injury in ACLF
Volume 55, Issue 4, Pages (October 2011)
Volume 69, Issue 2, Pages (August 2018)
Inflammation and portal hypertension – The undiscovered country
Divya Gupta et al. JCHF 2013;1:
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Contrast-induced nephropathy
Vicente Arroyo, Carlos Terra, Pere Ginès  Journal of Hepatology 
Ariane Mallat, Sophie Lotersztajn  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Volume 59, Issue 3, Pages (September 2013)
Sinusoidal communication in liver fibrosis and regeneration
Carmen Peralta, Mónica B. Jiménez-Castro, Jordi Gracia-Sancho 
Yasuko Iwakiri, Vijay Shah, Don C. Rockey  Journal of Hepatology 
Efren Rael, MD, FAAAAI  Journal of Allergy and Clinical Immunology 
The heart in liver transplantation
The sources of oxidative stress in the vessel wall
Chapter 14 Blood Pressure – Regulation and Pathology
Volume 66, Issue 1, Pages (January 2017)
Guo-Wei He, MD, DSc, David P. Taggart, FRCS 
Thomas Quaschning, Jan Galle, Christoph Wanner
Margus Annuk, Mihkel Zilmer, Bengt Fellström
Volume 132, Issue 2, Pages (February 2007)
Volume 70, Issue 10, Pages (November 2006)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
NASH animal models: Are we there yet?
A New Treatment for Portal Hypertension?
Volume 86, Issue 2, Pages (August 2014)
Volume 41, Issue 3, Pages (September 2004)
Immigration and viral hepatitis
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Mary P. Kotlarczyk, PhD, Marie Billaud, PhD, Benjamin R
Anthony M. Dewar, Richard A. Clark, Adam J. Singer, Mary D. Frame 
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Manuel Hernández-Guerra, Anna Hadjihambi, Rajiv Jalan 
Pathogenesis of cholestatic hepatitis C
Douglas A. Simonetto, MD, Mengfei Liu, MD, Patrick S. Kamath, MD 
Adel Hammoutene, Pierre-Emmanuel Rautou  Journal of Hepatology 
Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms to potential therapies  Ben M Tsai, MD, Meijing Wang, MD, Mark W Turrentine,
Biology of endothelin receptors in the collecting duct
Volume 61, Issue 2, Pages (August 2014)
Platelets arrive at the scene of fibrosis……studies
Presentation transcript:

Functional aspects on the pathophysiology of portal hypertension in cirrhosis  Juan-Carlos García-Pagán, Jorge Gracia-Sancho, Jaume Bosch  Journal of Hepatology  Volume 57, Issue 2, Pages 458-461 (August 2012) DOI: 10.1016/j.jhep.2012.03.007 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Pathophysiology of portal hypertension. Intrahepatic vascular resistance increment due to architectural disturbances and to increased hepatic vascular tone leads to portal hypertension development. Splanchnic arteriolar vasodilation together with elevated cardiac output due to systemic hypotension aggravates and perpetuate this syndrome. Journal of Hepatology 2012 57, 458-461DOI: (10.1016/j.jhep.2012.03.007) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Intrahepatic vascular resistance modulation. Hyperactive hepatic stellate cells overcontract in response to several vasoactive mediators from neighbor cells or from systemic circulation. Sinusoidal endothelial cells exhibit a marked dysfunctional phenotype defined by reduced vasodilators bioavailability, mainly nitric oxide (NO) but probably also carbon monoxide (CO) and hydrogen sulfide (H2S), and exaggerated vasoconstrictors production. Kupffer cells further contribute to HSC vasoconstriction liberating, among others, thromboxane A2 (TXA2) and cysteinyl-leukotrienes (CysLT). ET-1, endothelin-1; ETR, endothelin receptor; UTR, urotensin-II receptor; PLA2, phospholipase A2; 5-LO, 5-lipooxygenase; COX-1, cyclooxygenase-1; PGH2, prostaglandin H2; TXA2S, thromboxane A2 synthase; TP, TXA2/PGH2 receptor; α1, α1 adrenergic receptor; O2−, superoxide; ONOO−, peroxynitrite; eNOS, endothelial nitric oxide synthase; ROS, reactive oxygen species; BH4, tetrahydrobiopterin; GC, guanylate cyclase; cGMP, cyclic guanosine monophosphate; Rho K, rho kinase; MLC, myosin light chain. Journal of Hepatology 2012 57, 458-461DOI: (10.1016/j.jhep.2012.03.007) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions